40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. (17th December 2018)

Record Type:: Journal Article
Title:: 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. (17th December 2018)
Main Title:: 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy
Authors:: Marton, C
Mercier-Letondal, P
Deschamps, M
Ferrand, C
Adotevi, O
Borg, C
Galaine, J
Godet, Y
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 10
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 10
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:
Page End:
Publication Date:: 2018-12-17
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy485.009 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12263.xml